Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Status:
Completed
Trial end date:
2011-09-08
Target enrollment:
Participant gender:
Summary
Children with fungal infections will be divided into two groups by weight. Children weighing
< 25 kg will receive a higher dose of study medication (per kg body weight) for 10 to 14 days
than children weighing > 25 kg.